Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration
Ørnbjerg, L. M., Linde, L., Georgiadis, S., Rasmussen, S. H., Lindström, U., Askling, J., Michelsen, B., Giuseppe, D. D., Wallman, J. K., Pavelka, K., Závada, J., Nissen, M. J., Jones, G. T., Relas, H., Pirilä, L., Tomšič, M., Rotar, Z., Geirsson, A. J., Gudbjornsson, B., Kristianslund, E. K., van sder Horst-Bruinsma, I., Loft, A. G., Laas, K., Iannone, F., Corrado, A., Ciurea, A., Santos, M. J., Santos, H., Codreanu, C., Akkoc, N., Gunduz, O. S., Glintborg, B., Østergaard, M., Hetland, M. L.
Seminars in arthritis and rheumatism, vol. 56, 152081
European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response
Christiansen, S. N., Ørnbjerg, L. M., Rasmussen, S. H., Loft, A. G., Askling, J., Iannone, F., Zavada, J., Michelsen, B., Nissen, M., Onen, F., Santos, M. J., Pombo-Suarez, M., Relas, H., Macfarlane, G. J., Tomsic, M., Codreanu, C., Gudbjornsson, B., Van der Horst-Bruinsma, I., Di Giuseppe, D., Glintborg, B., Gremese, E., Pavelka, K., Kristianslund, E. K., Ciurea, A., Akkoc, N., Barcelos, A., Sánchez-Piedra, C., Peltomaa, R., Jones, G. T., Rotar, Z., Ionescu, R., Grondal, G., Van de Sande, M. G., Laas, K., Østergaard, M., Hetland, M. L.
Rheumatology (Oxford, England), vol. 61, no. 9, pp. 3799-3807
Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs
Tucker, L., Allen, A., Chandler, D., Ciurtin, C., Dick, A., Foulkes, A., Gullick, N., Helliwell, P., Jadon, D., Jones, G., Kyle, S., Madhok, V., McHugh, N., Parkinson, A., Raine, T., Siebert, S., Smith, C., Tillett, W., Coates, L. C.
Rheumatology (Oxford, England), vol. 61, no. 9, pp. 3514-3520
